Comparative evaluation of vestibular incision subperiosteal tunnel access and coronally advanced flap in adjunction with platelet-rich fibrin for maxillary gingival recession - A randomized controlled study

前庭切口骨膜下隧道入路联合冠向推进瓣及富血小板纤维蛋白治疗上颌牙龈退缩的比较评价——一项随机对照研究

阅读:1

Abstract

BACKGROUND: Gingival recession requires root coverage to address esthetics and dentinal hypersensitivity, prevent root caries and abrasion, and improve plaque control. The coronally advanced flap (CAF) with subepithelial connective tissue graft (SCTG) is a widely accepted gold standard but is technique sensitive and less predictable. The vestibular incision subperiosteal tunnel access (VISTA) technique is a minimally invasive alternative that yields more predictable results and better patient compliance. Platelet-rich fibrin (PRF) as a membrane for covering defects is less technique sensitive and improves patient comfort compared to SCTG. This study aims to compare the effectiveness of VISTA and CAF, both combined with PRF, in treating maxillary gingival recession. MATERIALS AND METHODS: This randomized controlled trial involved 30 sites (15 in each group) in patients with Cairo et al. recession type 1 (RT1) recession. Sites were assigned to the test group (VISTA + PRF) or the control group (CAF + PRF). Primary outcomes, including probing depth (PD), clinical attachment level (CAL), width of keratinized tissue, thickness of attached gingiva (TAG), vertical depth of recession (VDR), gingival recession width (GRW), and percentage root coverage (%RC), were assessed at baseline and 3 months. Secondary outcomes included postsurgical discomfort, evaluated immediately after surgery and at 1 week. RESULTS: On comparison of the groups, statistically more significant results in terms of PD, CAL, TAG, VDR, GRW, percentage root coverage, and postsurgical discomfort level were seen in the test group compared to the control group. CONCLUSION: Both VISTA + PRF and CAF + PRF effectively treat maxillary anterior gingival recession (Cairo et al. RT1), but VISTA + PRF shows superior outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。